Alprostadil Urethral Suppository
Alprostadil
Approved non-tablet option for people who cannot use PDE5 inhibitors.
- Type
- Prescription intraurethral pellet
- Regulatory
- FDA Approved
- Verification
- Well Established
- Editorial
- Brief
- Onset
- 5–10 min
- Duration
- 30–60 min